Description

Omalizumab Injection is a monoclonal antibody used to treat moderate to severe asthma and chronic spontaneous urticaria. By inhibiting immunoglobulin E (IgE), it reduces allergic responses, alleviates asthma symptoms, and improves overall quality of life for patients with these conditions.